TL;DR
This blog post highlights the top pre-market gainers for Thursday, focusing on stocks such as Immutep Limited ($IMMP), GLSI, NEOS, and UTSI. It includes recent news about Immutep's advancements in metastatic breast cancer studies and links to additional resources for investors.
ABNB IPO
| IMMP [NASD] |
| Immutep Limited |
| Healthcare | Biotechnology | Australia |
120% 100mc 46f
| Dec-09-20 05:53PM | |
| 05:14PM |
Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull
Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save
Watchlist 👉👉 https://tradejournal.co/post/friday-pre-market-top-gainers-immp-glsi-neos-utsi/
The top pre-market gainers discussed are Immutep Limited ($IMMP), GLSI, NEOS, and UTSI.
Immutep Limited's Chinese partner, EOC Pharma, is set to start a Phase II study for metastatic breast cancer, and the company reported significant survival benefits in its ongoing Phase IIb AIPAC study.
Additional information can be found in the provided links, including a live stream and a research recap video.
Yes, the blog mentions a free gap scanner and a chance to win two free stocks, each valued up to $1600.
The Phase II studies are crucial as they assess the efficacy and safety of treatments in a larger group of patients, which can lead to potential advancements in cancer therapies.
Portfolio(s): Day Trading Momo,
Portfolio(s): Swing Trading Momo, Day Trading Momo,
Portfolio(s): Swing Trading Momo, Day Trading Momo,
Learn more about trading journals and how to improve your performance:
Discover the 3 features that make a trading journal profitable: time savings, AI pattern detection, and free mentorship.
Download our free Excel and Google Sheets templates to start journaling today. Perfect for beginners!
Get a FREE 20-minute 1-on-1 onboarding call ($300 value) with every TradeJournal subscription.
